Interferon-alpha for treating polycythemia vera yields improved myelofibrosis-free and overall survival
Author(s) -
Ghaith AbuZeinah,
Spencer Krichevsky,
Tatiana Cruz,
Gabriela Hoberman,
Diana Jaber,
Niamh Savage,
Claudia Sosner,
Ellen K. Ritchie,
Joseph M. Scandura,
Richard T. Silver
Publication year - 2021
Publication title -
leukemia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.539
H-Index - 192
eISSN - 1476-5551
pISSN - 0887-6924
DOI - 10.1038/s41375-021-01183-8
Subject(s) - myelofibrosis , medicine , polycythemia vera , gastroenterology , phlebotomy , alpha interferon , ruxolitinib , retrospective cohort study , lower risk , confidence interval , surgery , interferon , immunology , bone marrow
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom